Home > Market Activity > Get Quotes > Company Information

Resverlogix Corp.

Exchange: TSX Exchange | Apr 25, 2019, 2:49 AM EDT

$ 3.99 real time data Change Down
-0.16 (-3.86%)
Real-time price
Day Low 3.99
Day High 4.33

Company Profile for Resverlogix Corp.

Description & Contact Information
Business Description: Resverlogix Corp clinical stage biotechnology company. Resverlogix is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Address: 4820 Richard Road SW, Suite 300, Calgary, AB, CAN, T3E 6L1
Telephone: +1 403 254-9252 Website: http://www.resverlogix.com
Facsimile: +1 403 256-8495 Email: sarah@resverlogix.com
Fiscal Year End: 04/2018
Industry Classifications
Sector: Healthcare CIK: 1372821
Industry: Biotechnology SIC: 3741
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges.
Market Data powered by QuoteMedia, Profiles by Morningstar. See the QuoteMedia Terms of Use.